Related Experiment Video

Updated: Jul 5, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

Causes of accidents in pediatric patients: what has changed through ages

M Falesi1, S Berni, M Strambi

  • 1Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Siena, Italy.

Minerva Pediatrica
|May 2, 2008
PubMed

Insights

Childhood accidents are a major cause of death and disability. A study in Siena found a significant reduction in hospital admissions for accidents over 20 years, indicating effective preventive measures.

Area of Science:

  • Pediatric Traumatology
  • Public Health
  • Epidemiology

Background:

  • Accidents are a leading cause of death and disability in children and adolescents (1-15 years).
  • In Italy, domestic and road accidents significantly impact this age group.
  • Previous data from 20 years ago provides a baseline for comparison.

Purpose of the Study:

  • To determine the incidence and types of accidents involving children and adolescents in Siena.
  • To compare current accident data with data from two decades prior.
  • To evaluate the effectiveness of implemented preventive measures.

Main Methods:

  • Analysis of hospital admission data for accidents in Siena between 1980-1985 and 2000-2006.
  • Examination of patient age, gender, and accident type.
  • Assessment of frequency distribution and peak accident ages.

Main Results:

  • Limb trauma was the most frequent cause of admission in the earlier period.
  • Head injuries without fracture became the most common in the later period, followed by limb trauma and fractures of the skull, spine, and trunk.
  • A consistent, gradual reduction in hospital admissions for accidents was observed over the years.

Conclusions:

  • A notable decrease in hospital admissions for childhood accidents was observed compared to 20 years prior.
  • Current preventive measures appear effective and should be continued.
  • Further interventions are recommended to further minimize accident-related injuries in children and adolescents.
Abstract

More Related Videos

Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury09:49

Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury

Published on: January 20, 2023

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...